Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0000950170-24-106856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-12 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.1 | +33.8K | 250.1K | +16% | +$3,375 |
| D | 2024-09-16 | 2024-09-12 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.00 | -33.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | M | A | 33,750 | $0.1 | 250,074 | D | — | — | (F1) Includes 215,185 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-09-12 | M | D | 33,750 | $0.00 | 0 | D | $0.1 · 2018-12-15 to 2024-12-15 | 33,750 Common Stock | (F2) The stock option vested in equal annual installments over 4 years, commencing on December 15, 2014 with the last installment vesting on December 15, 2018. |